Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Genetic Mutation as a Predicti...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Genetic Mutation as a Predictive Biomarker for FOLFIRINOX in Patients with Metastatic Pancreatic Adenocarcinoma

Genetic Mutation as a Predictive Biomarker for FOLFIRINOX in Patients with Metastatic Pancreatic Adenocarcinoma

Bibliographic Details
Main Author: Jaihwan Kim
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2019-06-01
Series:The Korean Journal of Gastroenterology
Online Access:http://www.kjg.or.kr/journal/view.html?uid=5468&vmd=Full&
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.kjg.or.kr/journal/view.html?uid=5468&vmd=Full&

Similar Items

  • Prognostic value of the mutation in patients with pancreatic ductal adenocarcinoma receiving FOLFIRINOX
    by: Min Kyu Kim, et al.
    Published: (2024-10-01)
  • Prolonged Complete Response in a Patient with Metastatic Pancreatic Adenocarcinoma after FOLFIRINOX Chemotherapy and Maintenance with FOLFIRI
    by: Christos Nikolaou, et al.
    Published: (2015-01-01)
  • FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
    by: Changhoon Yoo, et al.
    Published: (2020-09-01)
  • Excellent Response to Olaparib in a Patient with Metastatic Pancreatic Adenocarcinoma with Germline BRCA1 Mutation after Progression on FOLFIRINOX: Case Report and Literature Review
    by: Jefferson Rios Pimenta, et al.
    Published: (2020-07-01)
  • Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients
    by: Dong Woo Shin, et al.
    Published: (2021-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs